Current and Resolved Drug Shortages and Discontinuations Reported to FDA
Report a Drug Shortage |
FAQ |
Background Info |
Get Email Alerts |
Download Current Drug Shortages |
Download Historical Drug Shortages
|
Contact Us
Start Over | Back to Previous Screen
Methylprednisolone Acetate Injection
Status: Currently in Shortage
»Date first posted:
12/15/2021
»Therapeutic Categories: Rheumatology
Amneal Pharmaceuticals (Revised 06/17/2026)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Methylprednisolone Acetate, Injection, 40 mg/1 mL (NDC 70121-1573-1) | Limited Availability | On backorder. Estimated recovery: late July | Other |
| Methylprednisolone Acetate, Injection, 40 mg/1 mL (NDC 70121-1573-5) | Available | ||
| Methylprednisolone Acetate, Injection, 80 mg/1 mL (NDC 70121-1574-1) | Available | ||
| Methylprednisolone Acetate, Injection, 80 mg/1 mL (NDC 70121-1574-5) | Available |
Eugia US LLC (Reverified 10/02/2026)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Methylprednisolone Acetate, Injection, 40 mg/1 mL (NDC 55150-313-01) | Unavailable | On backorder. Recovery: TBD. Check wholesalers for inventory | Demand increase for the drug |
| Methylprednisolone Acetate, Injection, 80 mg/1 mL (NDC 55150-314-01) | Unavailable | On backorder. Recovery: TBD. Check wholesalers for inventory | Demand increase for the drug |
Par Health, USA LLC (Reverified 10/02/2026)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Methylprednisolone Acetate, Injection, 80 mg/1 mL (NDC 42023-240-01) | Unavailable | Estimated recovery: TBD | Other |
Pfizer Inc. (Reverified 09/21/2026)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Depo-medrol, Injection, 20 mg/1 mL (NDC 0009-0274-01) | Available | ||
| Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-0280-02) | Available | ||
| Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-0280-03) | Limited Availability | Limited Supply Available. Next Delivery: November 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay | Other |
| Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-0280-51) | Available | ||
| Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-0280-52) | Available | ||
| Depo-medrol, Injection, 80 mg/1 mL (NDC 0009-0306-02) | Available | ||
| Depo-medrol, Injection, 80 mg/1 mL (NDC 0009-0306-12) | Available | ||
| Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-3073-01) | Limited Availability | Limited Supply Available. Next Delivery: October 2026; Estimated Recovery: December 2026 | Demand increase for the drug |
| Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-3073-03) | Limited Availability | Limited Supply Available. Next Delivery: September 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay | Other |
| Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-3073-22) | Unavailable | Next Delivery: October 2026; Estimated Recovery: December 2026 | Demand increase for the drug |
| Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-3073-23) | Unavailable | Next Delivery: October 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay | Other |
| Depo-medrol, Injection, 80 mg/1 mL (NDC 0009-3475-01) | Limited Availability | Limited Supply Available. Next Delivery and Estimated Recovery: December 2026 | Demand increase for the drug |
| Depo-medrol, Injection, 80 mg/1 mL (NDC 0009-3475-03) | Limited Availability | Limited Supply Available. Next Delivery: September 2026; Estimated Recovery: March 2027; Shortage per Manufacturer: Manufacturing Delay | Other |
Sagent Pharmaceuticals (Revised 09/18/2026)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Methylprednisolone Acetate, Injection, 40 mg/1 mL (NDC 25021-820-10) | Unavailable | Estimated recovery: November 2026, | Shortage of an active ingredient |
| Methylprednisolone Acetate, Injection, 40 mg/1 mL (NDC 25021-820-05) | Unavailable | Estimated recovery: November 2026 | Shortage of an active ingredient |
| Methylprednisolone Acetate, Injection, 80 mg/1 mL (NDC 25021-821-05) | Limited Availability | Estimated recovery: November 2026, Product on hand is 8-12 months of dating prior to expiry | Shortage of an active ingredient |